Building In Vivo Clinical Success Leveraging the IIT Pathway to Accelerate Global Clinical Development

• Expand clinical momentum by leveraging the IIT pathway to generate early human data across BCMA in vivo CAR and CD19 CAR-T
• Utilizing clinical insights to inform development strategy
• Sharing practical learnings from IND and IIT discussions to navigate regulatory engagement effectively

Speakers:

Yongke Zhang

CSO

IASO Biotherapeutics